메뉴 건너뛰기




Volumn 111, Issue SUPPL. 1, 2009, Pages

UK renal registry 11th annual report (December 2008): Chapter 14 UK renal registry and international comparisons

Author keywords

Cardiovascular risk factors; Epidemiology; International comparison; Renal Registry

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; DEMOGRAPHY; DISEASE REGISTRY; HUMAN; INCIDENCE; KIDNEY FAILURE; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; UNITED KINGDOM;

EID: 68249103928     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210003     Document Type: Article
Times cited : (38)

References (17)
  • 1
    • 32844464234 scopus 로고    scopus 로고
    • Exploring the differences in epidemiology of treated ESRD between Germany and England and Wales
    • Caskey FJ, Schober-Halstenberg HJ, Roderick PJ, et al. Exploring the differences in epidemiology of treated ESRD between Germany and England and Wales. Am J Kidney Dis 2006;47(3):445.
    • (2006) Am J Kidney Dis , vol.47 , Issue.3 , pp. 445
    • Caskey, F.J.1    Schober-Halstenberg, H.J.2    Roderick, P.J.3
  • 2
    • 33746056444 scopus 로고    scopus 로고
    • The enigma of hypertensive ESRD: Observations on incidence and trends in 18 European, Canadian, and Asian-Pacific populations, 1998 to 2002
    • Stewart JH, McCredie MR, Williams SM, et al. The enigma of hypertensive ESRD: observations on incidence and trends in 18 European, Canadian, and Asian-Pacific populations, 1998 to 2002. Am J Kidney Dis 2006;48(2):183.
    • (2006) Am J Kidney Dis , vol.48 , Issue.2 , pp. 183
    • Stewart, J.H.1    McCredie, M.R.2    Williams, S.M.3
  • 3
    • 0032844409 scopus 로고    scopus 로고
    • Healthcare systems and end-stage renal disease (ESRD) therapies - an international review: Costs and reimbursement/funding of ESRD therapies
    • De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) therapies - an international review: costs and reimbursement/funding of ESRD therapies. Nephrol. Dial. Transplant. 1999;14(suppl-6):31.
    • (1999) Nephrol. Dial. Transplant , vol.14 , Issue.SUPPL.-6 , pp. 31
    • De Vecchi, A.F.1    Dratwa, M.2    Wiedemann, M.E.3
  • 4
    • 31644438457 scopus 로고    scopus 로고
    • Cardiovascular risk factors in chronic kidney disease
    • Menon V, Gul A, Sarnak MJ. Cardiovascular risk factors in chronic kidney disease. Kidney Int 2005;68(4):1413.
    • (2005) Kidney Int , vol.68 , Issue.4 , pp. 1413
    • Menon, V.1    Gul, A.2    Sarnak, M.J.3
  • 5
    • 0031733696 scopus 로고    scopus 로고
    • Clinical epidemiology of cardiovascular disease in chronic renal disease
    • Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32(5 Suppl 3):S112.
    • (1998) Am J Kidney Dis , vol.32 , Issue.5 SUPPL. 3
    • Foley, R.N.1    Parfrey, P.S.2    Sarnak, M.J.3
  • 6
    • 0034976253 scopus 로고    scopus 로고
    • Renal replacement therapy in Europe: The results of a collaborative effort by the ERA-EDTA registry and six national or regional registries
    • van Dijk PCW, Jager KJ, de Charro F, et al. Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol. Dial. Transplant. 2001; 16(6):1120.
    • (2001) Nephrol. Dial. Transplant , vol.16 , Issue.6 , pp. 1120
    • van Dijk, P.C.W.1    Jager, K.J.2    de Charro, F.3
  • 7
    • 68249124177 scopus 로고    scopus 로고
    • : Factors which may Influence Cardiovascular Disease -Blood Pressure and Serum Cholesterol
    • Bristol: UK Renal Registry
    • Ansell D, Feest TG. Chapter 11: Factors which may Influence Cardiovascular Disease -Blood Pressure and Serum Cholesterol. The Eighth Annual Report. Bristol: UK Renal Registry, 2005.
    • (2005) The Eighth Annual Report
    • Ansell, D.1    Feest, T.G.2
  • 8
    • 68249096097 scopus 로고    scopus 로고
    • U.S. Renal Data System. USRDS 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States: National Institute of Diabetes and Digestive and Kidney Diseases, 2008.
    • U.S. Renal Data System. USRDS 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States: National Institute of Diabetes and Digestive and Kidney Diseases, 2008.
  • 9
    • 68249089335 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis 2003;41(4 Suppl 3):I
    • K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis 2003;41(4 Suppl 3):I.
  • 10
    • 3042819708 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004;43(5 Suppl 1):S1
    • K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004;43(5 Suppl 1):S1.
  • 11
    • 33845760213 scopus 로고    scopus 로고
    • KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007;49(2 Suppl 2):S12
    • KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007;49(2 Suppl 2):S12.
  • 12
    • 68249090423 scopus 로고    scopus 로고
    • Chapter 3: Health status, Illnesses and Other Comorbid Conditions. In: Dolman R, King-don A, Roberts C, eds. Welsh Health Survey. Cardiff: Statistics for Wales, 2007.
    • Chapter 3: Health status, Illnesses and Other Comorbid Conditions. In: Dolman R, King-don A, Roberts C, eds. Welsh Health Survey. Cardiff: Statistics for Wales, 2007.
  • 13
    • 68249122749 scopus 로고    scopus 로고
    • 2: Risk factors for cardiovascular disease. In: Sproston K, Primatesta P, eds. Health Survey for England 2003. London: National Centre for Social Research and Department of Epidemiology and Public Health at the Royal Free and University College Medical School, 2004.
    • Volume 2: Risk factors for cardiovascular disease. In: Sproston K, Primatesta P, eds. Health Survey for England 2003. London: National Centre for Social Research and Department of Epidemiology and Public Health at the Royal Free and University College Medical School, 2004.
  • 14
    • 68249127505 scopus 로고    scopus 로고
    • Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure. London: National Institute of Clinical Excellence, 2002.
    • Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure. London: National Institute of Clinical Excellence, 2002.
  • 16
    • 4644272251 scopus 로고    scopus 로고
    • Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): Demographic and baseline characteristics
    • Wanner C, Krane V, Marz W, et al. Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics. Kidney Blood Press Res 2004;27(4):259.
    • (2004) Kidney Blood Press Res , vol.27 , Issue.4 , pp. 259
    • Wanner, C.1    Krane, V.2    Marz, W.3
  • 17
    • 33748911806 scopus 로고    scopus 로고
    • The epidemiology of systolic blood pressure and death risk in hemodialysis patients
    • Li Z, Lacson E, Jr., Lowrie EG, et al. The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis 2006;48(4):606.
    • (2006) Am J Kidney Dis , vol.48 , Issue.4 , pp. 606
    • Li, Z.1    Lacson Jr., E.2    Lowrie, E.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.